Previous 10 | Next 10 |
NEWTOWN, Pa., June 05, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that three new clinics have been authorized to provide PoNS...
Glancy Prongay & Murray LLP (“GPM”) announces the continuation of its investigation on behalf of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors concerning the Company and its officers’ possible vio...
Helius Medical Technologies, Inc. (HSDT) Q1 2019 Earnings Conference Call May 9, 2019 16:30 ET Company Participants Phil Deschamps - CEO Joyce LaViscount - CFO & COO Conference Call Participants Marie Thibault - BTIG Presentation Operator Good afternoon, ladies ...
Helius Medical Technologies (NASDAQ: HSDT ): Q1 GAAP EPS of -$0.06 beats by $0.20 . More news on: Helius Medical Technologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
NEWTOWN, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the first quarter ended March 31, 2019...
Establishment Labs Could Become The Next Hot Medtech Growth Stock Establishment Labs ( ESTA ) manufactures and sells medical devices for aesthetic and reconstructive plastic surgery. It primarily offers silicone gel-filled smooth category breast implants under the Motiva Implants brand nam...
April 18, 2019 Palm Beach, FL –April 18, 2019 – The global cellulite market and its largest segment, the non-invasive treatment sector, are both expected to grow at a healthy rate. A recent industry report on the entire cellulite market (from Transparency Market Research)...
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Helius Medical Technologies, Inc. (“Helius” or the “Company”) (NASDAQ: HSDT ) investors concerning the Company and its officers’ possible violations of federal se...
We Found No Fundamental Justification For CFMS 400% Rally We at White Diamond Research are medical device experts. Recently, we have been exposing medical device companies that have inferior devices. Over the last eight months, we have published on Seeking Alpha bearish reports on the follow...
The FDA has rejected Helius Medical Technologies' (NASDAQ: HSDT ) application for De Novo status and 510(k) clearance of its Portable Neuromodulation Stimulator (PoNS). The agency cited the lack of sufficient information to determine the relative contributions of the PoNS device and physic...
News, Short Squeeze, Breakout and More Instantly...
Helius Medical Technologies Inc. Company Name:
HSDT Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 30.3% to $0.2932 on volume of 173,918,707 shares Emergent Biosolutions Inc. (EBS) rose 71.0% to $3.3 on volume of 150,987,238 shares PROSHARES TRUST (SQQQ) fell 3.6% to $11.78 on volume of 136,332,744 sh...